ANI Pharmaceuticals, Inc. (ANIP): Price and Financial Metrics

ANIP POWR Grades

• Growth is the dimension where ANIP ranks best; there it ranks ahead of 96.42% of US stocks.
• ANIP's strongest trending metric is Growth; it's been moving up over the last 177 days.
• ANIP's current lowest rank is in the Momentum metric (where it is better than 7.21% of US stocks).

ANIP Stock Summary

• With a one year PEG ratio of 61.61, ANI PHARMACEUTICALS INC is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 68.67% of US stocks.
• Of note is the ratio of ANI PHARMACEUTICALS INC's sales and general administrative expense to its total operating expenses; 34.86% of US stocks have a lower such ratio.
• Revenue growth over the past 12 months for ANI PHARMACEUTICALS INC comes in at 46.38%, a number that bests 83.26% of the US stocks we're tracking.
• Stocks with similar financial metrics, market capitalization, and price volatility to ANI PHARMACEUTICALS INC are MRAI, TKNO, AGFS, XRX, and XMTR.
• Visit ANIP's SEC page to see the company's official filings. To visit the company's web site, go to www.anipharmaceuticals.com.

ANIP Valuation Summary

• ANIP's price/sales ratio is 2.1; this is 10.53% higher than that of the median Healthcare stock.
• ANIP's price/sales ratio has moved down 3.5 over the prior 243 months.

Below are key valuation metrics over time for ANIP.

ANIP Growth Metrics

The 4 year price growth rate now stands at -32%.
• The 3 year cash and equivalents growth rate now stands at 89.43%.
• Its 3 year net cashflow from operations growth rate is now at -162.1%.

Over the past 67 months, ANIP's revenue has gone up $138,387,000.

The table below shows ANIP's growth in key financial areas (numbers in millions of US dollars).

Date	Revenue	Operating Cash Flow	Net Income to Common Stock
2022-09-30	283.082	-38.988	-69.197
2022-06-30	251.322	-48.013	-64.638
2022-03-31	226.092	-36.288	-63.414
2021-12-31	216.136	3.322	-42.793
2021-09-30	212.459	9.798	-22.102
2021-06-30	213.377	13.586	-17.221

ANIP's Quality Factors

The “Quality” component of the POWR Ratings focuses on 31 different factors of a companies fundamentals and operational strength. Here are some key insights as we drill into the specifics of these quality attributes.

• ANIP has a Quality Grade of D, ranking ahead of 9.89% of graded US stocks.
• ANIP's asset turnover comes in at 0.453 -- ranking 96th of 682 Pharmaceutical Products stocks.
• NWBO, CYTR, and NAII are the stocks whose asset turnover ratios are most correlated with ANIP.

The table below shows ANIP's key quality metrics over time.